---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-26T10:22:56.886377'
end_time: '2025-12-26T10:27:15.588364'
duration_seconds: 258.7
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: ARCN1
  gene_symbol: ARCN1
  uniprot_accession: P48444
  protein_description: 'RecName: Full=Coatomer subunit delta; AltName: Full=Archain;
    AltName: Full=Delta-coat protein; Short=Delta-COP;'
  gene_info: Name=ARCN1; Synonyms=COPD;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the adaptor complexes medium subunit family.
  protein_domains: AP2_Mu_C_sf. (IPR036168); AP_mu_sigma_su. (IPR022775); Coatomer_dsu.
    (IPR027059); Longin-like_dom_sf. (IPR011012); MHD. (IPR028565)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 4
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P48444
- **Protein Description:** RecName: Full=Coatomer subunit delta; AltName: Full=Archain; AltName: Full=Delta-coat protein; Short=Delta-COP;
- **Gene Information:** Name=ARCN1; Synonyms=COPD;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the adaptor complexes medium subunit family.
- **Key Domains:** AP2_Mu_C_sf. (IPR036168); AP_mu_sigma_su. (IPR022775); Coatomer_dsu. (IPR027059); Longin-like_dom_sf. (IPR011012); MHD. (IPR028565)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "ARCN1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'ARCN1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **ARCN1** (gene ID: ARCN1, UniProt: P48444) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P48444
- **Protein Description:** RecName: Full=Coatomer subunit delta; AltName: Full=Archain; AltName: Full=Delta-coat protein; Short=Delta-COP;
- **Gene Information:** Name=ARCN1; Synonyms=COPD;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the adaptor complexes medium subunit family.
- **Key Domains:** AP2_Mu_C_sf. (IPR036168); AP_mu_sigma_su. (IPR022775); Coatomer_dsu. (IPR027059); Longin-like_dom_sf. (IPR011012); MHD. (IPR028565)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "ARCN1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'ARCN1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **ARCN1** (gene ID: ARCN1, UniProt: P48444) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity verified: ARCN1 encodes delta-COP (coatomer subunit delta), a core component of the heptameric COPI coat; human disease-causing ARCN1 variants were identified in 2016 (Am J Hum Genet), consistent with the UniProt description and Homo sapiens context. ARCN1 functions within COPI-mediated ER–Golgi trafficking and localizes to ER/Golgi membranes as part of coatomer; these points are supported by Izumi et al., 2016 and earlier functional studies in mouse and cell systems (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 6-7, izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5, wagner2011linkingpigmentationdefects pages 1-2).

Comprehensive research report on ARCN1 (delta-COP, UniProt P48444)
1) Key concepts and definitions
- Gene/protein definition: ARCN1 (archain 1) encodes the delta subunit of coatomer (delta-COP), one of seven COPI subunits (α-, β-, β′-, γ-, δ-, ε-, ζ-COP) that assemble on Golgi/ER membranes to form COPI-coated vesicles for intracellular trafficking (Izumi et al., 2016; Am J Hum Genet 99:451–459, published July 28, 2016; doi:10.1016/j.ajhg.2016.06.011; URL: https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Primary biological role: COPI primarily mediates retrograde transport from the Golgi apparatus back to the endoplasmic reticulum (ER) and transport within the Golgi; delta-COP is an essential coatomer subunit required for these processes (Izumi et al., 2016) (izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 2-4).
- Cargo-recognition concept: Delta-COP recognizes arginine-based ER retrieval signals on membrane proteins and interacts with ARF1 and ER tethers (e.g., Dsl1p) to drive vesicle formation and targeting, connecting cargo selection to budding and tethering steps (Wagner and Hammer, 2011 commentary) (wagner2011linkingpigmentationdefects pages 1-2).
- Cellular localization: Delta-COP/ARCN1 localizes to the Golgi and ER as part of coatomer on budding COPI vesicles; perturbation causes ER stress and Golgi trafficking defects (Izumi et al., 2016; Wagner and Hammer, 2011) (izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, wagner2011linkingpigmentationdefects pages 1-2, izumi2016arcn1mutationscause pages 4-5).

2) Recent developments and latest research (emphasis on 2016–2024 where available in the evidence)
- Human genetic disease discovery: Heterozygous loss-of-function ARCN1 variants cause a recognizable craniofacial syndrome with micrognathia, rhizomelic shortening, short stature, microcephaly, and mild developmental delay; mechanistic studies implicate defective COPI-mediated transport and ER stress, including intracellular type I collagen accumulation and reduced secretion (Izumi et al., 2016; published July 28, 2016; https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 6-7, izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Experimental phenotypes linking ARCN1 to neurobiology and proteostasis: A mouse ENU missense mutation in Arcn1 (nur17) causes coat-color dilution and progressive Purkinje cell degeneration; mutant melanocytes exhibit disrupted intracellular trafficking, abnormal protein accumulation, and ER stress, connecting delta-COP function to neuronal homeostasis (PLoS Genet, 2010; doi:10.1371/journal.pgen.1000956; URL: https://doi.org/10.1371/journal.pgen.1000956) (izumi2016arcn1mutationscause pages 5-6).
- Mechanistic clarifications around cargo and retrieval signals: Commentary summarizing delta-COP’s recognition of arginine-based retrieval motifs and interactions with ARF1 and tethering complexes consolidates the view of delta-COP as a cargo-recognition/coat component coupling to targeting machinery (Wagner and Hammer, 2011) (wagner2011linkingpigmentationdefects pages 1-2).
- Note on recent literature gap: Within the gathered evidence set, post-2019–2024 primary updates specific to human ARCN1 are limited; consequently, the most direct human mechanistic insights derive from Izumi et al., 2016 and earlier functional models. Additional 2019–2024 developments exist broadly for COPI biology, but ARCN1-specific peer-reviewed updates were not retrieved in our evidence scan and are therefore not cited here (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6).

3) Current applications and real-world implementations
- Clinical genetics and diagnostics: ARCN1 should be considered in genetic evaluation of patients with micrognathia, rhizomelic shortening, microcephaly, and proportionate short stature. Izumi et al. demonstrated truncating/frameshift variants (e.g., p.Ser87*, p.Val212Trpfs*15, p.Ser53Cysfs*39) segregating with disease, and functional assays confirmed haploinsufficiency and COPI-transport defects, supporting inclusion of ARCN1 in gene panels for craniofacial and skeletal dysmorphology (Am J Hum Genet 2016; https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5, izumi2016arcn1mutationscause pages 1-2).
- Mechanism-guided pathology workups: Cellular assays for ER stress markers (ATF4, DDIT3/CHOP, HSPA5/BiP) and collagen trafficking/secretion can substantiate suspected delta-COP dysfunction in patient-derived fibroblasts, as used by Izumi et al. (2016) to demonstrate pathomechanism (https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Research models: The Arcn1 nur17 mouse provides an in vivo model linking impaired COPI trafficking to neurodegeneration and pigmentation defects, enabling preclinical exploration of ER stress–modulating or trafficking-corrective strategies (PLoS Genet 2010; https://doi.org/10.1371/journal.pgen.1000956) (izumi2016arcn1mutationscause pages 5-6).

4) Expert opinions and analysis from authoritative sources
- Causal inference and essentiality: Izumi et al. concluded that ARCN1 is dosage-sensitive and likely essential for viability of human cells, as biallelic knockouts were not recovered; their data argue that impaired COPI retrograde transport directly causes intracellular collagen retention and ER stress, rather than ER stress alone being sufficient for collagen retention (Am J Hum Genet 2016; https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Functional mechanistic perspective: Commentary and model-organism work emphasize delta-COP’s role in recognizing ER retrieval motifs, coordinating with ARF1 and ER tethers, and maintaining trafficking fidelity required for neuronal and pigment cell function; these analyses support the view that precise COPI function is crucial for proteostasis and specialized cell biology (Wagner and Hammer, 2011; Xu et al., 2010; https://doi.org/10.1371/journal.pgen.1000956) (wagner2011linkingpigmentationdefects pages 1-2, izumi2016arcn1mutationscause pages 5-6).

5) Relevant statistics and data from recent studies
- Human cohort size and phenotype breadth: Izumi et al. reported a series of individuals with heterozygous ARCN1 truncating/frameshift variants showing a consistent craniofacial–skeletal phenotype, including severe micrognathia, rhizomelic limb shortening, microcephalic dwarfism, joint laxity, and mild developmental delay/intellectual disability; seizures occurred in one case but attribution was confounded (Am J Hum Genet 2016; published July 28, 2016; https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Cellular assays: ARCN1 knockdown/mutation elevated ER stress markers (e.g., ATF4, DDIT3, HSPA5), caused intracellular accumulation and reduced secretion of type I collagen, and was phenocopied by brefeldin A treatment that impairs ER–Golgi transport (Am J Hum Genet 2016; https://doi.org/10.1016/j.ajhg.2016.06.011) (izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Animal model outcomes: The Arcn1 nur17 mouse exhibited coat-color dilution and cerebellar Purkinje cell degeneration with ER stress and abnormal protein accumulation, reflecting conserved requirements for delta-COP in trafficking and neuronal survival (PLoS Genet 2010; https://doi.org/10.1371/journal.pgen.1000956) (izumi2016arcn1mutationscause pages 5-6).

Functional and pathway summary
- Molecular function: Structural coat/adaptor component of COPI; required for cargo selection and coat assembly, including recognition of arginine-based retrieval signals on membrane proteins (wagner2011linkingpigmentationdefects pages 1-2, izumi2016arcn1mutationscause pages 1-2).
- Pathway placement: COPI-mediated retrograde transport (Golgi→ER) and intra-Golgi trafficking within the early secretory pathway (izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6).
- Subcellular localization: Golgi and ER membranes as part of coatomer/COPI-coated vesicles (izumi2016arcn1mutationscause pages 1-2, wagner2011linkingpigmentationdefects pages 1-2).
- Disease linkage: Haploinsufficient ARCN1 causes a recognizable craniofacial–skeletal syndrome in humans; impaired collagen trafficking and ER stress likely underlie aspects of the phenotype (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 4-5).
- Neurobiology: Mouse Arcn1 hypomorph demonstrates neurodegeneration and ER stress; supports a role for precise COPI function in neuronal proteostasis (izumi2016arcn1mutationscause pages 5-6, wagner2011linkingpigmentationdefects pages 1-2).

Limitations and open questions
- Within the available evidence, detailed human ARCN1 domain architecture and comprehensive 2019–2024 clinical expansions were not retrieved, and recent cancer-focused associations remain to be clarified. Future work integrating human genetics, proteomics, and high-resolution structural studies of coatomer will refine ARCN1’s interaction surfaces and disease mechanisms.

Primary sources cited (with URLs and dates)
- Izumi K et al., ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects. American Journal of Human Genetics. Published July 28, 2016. DOI: 10.1016/j.ajhg.2016.06.011. URL: https://doi.org/10.1016/j.ajhg.2016.06.011 (izumi2016arcn1mutationscause pages 7-8, izumi2016arcn1mutationscause pages 1-2, izumi2016arcn1mutationscause pages 5-6, izumi2016arcn1mutationscause pages 6-7, izumi2016arcn1mutationscause pages 2-4, izumi2016arcn1mutationscause pages 4-5).
- Xu X et al., Mutation in Archain 1, a Subunit of COPI Coatomer Complex, Causes Diluted Coat Color and Purkinje Cell Degeneration. PLoS Genetics. Published May 27, 2010. DOI: 10.1371/journal.pgen.1000956. URL: https://doi.org/10.1371/journal.pgen.1000956 (izumi2016arcn1mutationscause pages 5-6).
- Wagner W and Hammer JA III, Linking pigmentation defects and neurodegeneration through membrane trafficking pathways: identification of a delta-COP mutant. 2011 commentary (publication details not fully captured in the excerpt) (wagner2011linkingpigmentationdefects pages 1-2).

References

1. (izumi2016arcn1mutationscause pages 7-8): Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa, Adeline Jacquinet, Yusuke Yamazumi, Shu-Ting Chen, Alain Verloes, Yuki Okada, Yuki Katou, Tomohiko Nakamura, Tetsu Akiyama, Pierre Gressens, Roger Foo, Sandrine Passemard, Ene-Choo Tan, Vincent El Ghouzzi, and Katsuhiko Shirahige. Arcn1 mutations cause a recognizable craniofacial syndrome due to copi-mediated transport defects. American journal of human genetics, 99 2:451-9, Aug 2016. URL: https://doi.org/10.1016/j.ajhg.2016.06.011, doi:10.1016/j.ajhg.2016.06.011. This article has 91 citations and is from a highest quality peer-reviewed journal.

2. (izumi2016arcn1mutationscause pages 1-2): Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa, Adeline Jacquinet, Yusuke Yamazumi, Shu-Ting Chen, Alain Verloes, Yuki Okada, Yuki Katou, Tomohiko Nakamura, Tetsu Akiyama, Pierre Gressens, Roger Foo, Sandrine Passemard, Ene-Choo Tan, Vincent El Ghouzzi, and Katsuhiko Shirahige. Arcn1 mutations cause a recognizable craniofacial syndrome due to copi-mediated transport defects. American journal of human genetics, 99 2:451-9, Aug 2016. URL: https://doi.org/10.1016/j.ajhg.2016.06.011, doi:10.1016/j.ajhg.2016.06.011. This article has 91 citations and is from a highest quality peer-reviewed journal.

3. (izumi2016arcn1mutationscause pages 5-6): Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa, Adeline Jacquinet, Yusuke Yamazumi, Shu-Ting Chen, Alain Verloes, Yuki Okada, Yuki Katou, Tomohiko Nakamura, Tetsu Akiyama, Pierre Gressens, Roger Foo, Sandrine Passemard, Ene-Choo Tan, Vincent El Ghouzzi, and Katsuhiko Shirahige. Arcn1 mutations cause a recognizable craniofacial syndrome due to copi-mediated transport defects. American journal of human genetics, 99 2:451-9, Aug 2016. URL: https://doi.org/10.1016/j.ajhg.2016.06.011, doi:10.1016/j.ajhg.2016.06.011. This article has 91 citations and is from a highest quality peer-reviewed journal.

4. (izumi2016arcn1mutationscause pages 6-7): Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa, Adeline Jacquinet, Yusuke Yamazumi, Shu-Ting Chen, Alain Verloes, Yuki Okada, Yuki Katou, Tomohiko Nakamura, Tetsu Akiyama, Pierre Gressens, Roger Foo, Sandrine Passemard, Ene-Choo Tan, Vincent El Ghouzzi, and Katsuhiko Shirahige. Arcn1 mutations cause a recognizable craniofacial syndrome due to copi-mediated transport defects. American journal of human genetics, 99 2:451-9, Aug 2016. URL: https://doi.org/10.1016/j.ajhg.2016.06.011, doi:10.1016/j.ajhg.2016.06.011. This article has 91 citations and is from a highest quality peer-reviewed journal.

5. (izumi2016arcn1mutationscause pages 2-4): Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa, Adeline Jacquinet, Yusuke Yamazumi, Shu-Ting Chen, Alain Verloes, Yuki Okada, Yuki Katou, Tomohiko Nakamura, Tetsu Akiyama, Pierre Gressens, Roger Foo, Sandrine Passemard, Ene-Choo Tan, Vincent El Ghouzzi, and Katsuhiko Shirahige. Arcn1 mutations cause a recognizable craniofacial syndrome due to copi-mediated transport defects. American journal of human genetics, 99 2:451-9, Aug 2016. URL: https://doi.org/10.1016/j.ajhg.2016.06.011, doi:10.1016/j.ajhg.2016.06.011. This article has 91 citations and is from a highest quality peer-reviewed journal.

6. (izumi2016arcn1mutationscause pages 4-5): Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa, Adeline Jacquinet, Yusuke Yamazumi, Shu-Ting Chen, Alain Verloes, Yuki Okada, Yuki Katou, Tomohiko Nakamura, Tetsu Akiyama, Pierre Gressens, Roger Foo, Sandrine Passemard, Ene-Choo Tan, Vincent El Ghouzzi, and Katsuhiko Shirahige. Arcn1 mutations cause a recognizable craniofacial syndrome due to copi-mediated transport defects. American journal of human genetics, 99 2:451-9, Aug 2016. URL: https://doi.org/10.1016/j.ajhg.2016.06.011, doi:10.1016/j.ajhg.2016.06.011. This article has 91 citations and is from a highest quality peer-reviewed journal.

7. (wagner2011linkingpigmentationdefects pages 1-2): W Wagner and JA Hammer III. Linking pigmentation defects and neurodegeneration through membrane trafficking pathways: identification of a delta-cop mutant. Unknown journal, 2011.

## Citations

1. wagner2011linkingpigmentationdefects pages 1-2
2. https://doi.org/10.1016/j.ajhg.2016.06.011
3. https://doi.org/10.1371/journal.pgen.1000956
4. https://doi.org/10.1016/j.ajhg.2016.06.011,